Valuation Integra LifeSciences Holdings Corporation
Stocks
IART
US4579852082
Medical Equipment, Supplies & Distribution
|
Market Closed -
Nasdaq
16:00:00 2026-08-13 EDT
|
5-day change | 1st Jan Change | ||
| 18.24 USD | +4.95% |
|
+6.67% | +46.86% |
| 07-30 | BMO Cuts Price Target on Integra LifeSciences Holdings to $18 From $19, Keeps Market Perform Rating | MT |
| 07-29 | Integra LifeSciences Holdings Corporation, Q2 2026 Earnings Call, Jul 29, 2026 |
Company Valuation: Integra LifeSciences Holdings Corporation
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 5,674 | 4,683 | 3,405 | 1,750 | 967.4 | 1,419 | - | - |
| Change | - | -17.47% | -27.3% | -48.6% | -44.72% | 46.63% | - | - |
| Enterprise Value (EV) 1 | 6,707 | 5,670 | 4,605 | 3,285 | 2,563 | 2,908 | 2,703 | 2,483 |
| Change | - | -15.47% | -18.78% | -28.66% | -21.98% | 13.45% | -7.03% | -8.15% |
| P/E | 33.8x | 26x | 51.8x | -252x | -1.84x | 28.5x | 14.7x | 11.2x |
| PBR | 3.37x | 2.6x | 2.14x | 1.13x | 0.93x | 1.22x | 1.08x | 0.96x |
| PEG | - | 2.86x | -0.8x | 2x | -0x | -0x | 0.2x | 0.4x |
| Capitalization / Revenue | 3.68x | 3.01x | 2.21x | 1.09x | 0.59x | 0.85x | 0.82x | 0.79x |
| EV / Revenue | 4.35x | 3.64x | 2.99x | 2.04x | 1.57x | 1.74x | 1.56x | 1.39x |
| EV / EBITDA | 16.7x | 13.8x | 12.5x | 10.2x | 8.07x | 8.45x | 7.45x | 6.43x |
| EV / EBIT | 21.4x | 15.5x | 14x | 11.7x | 9.33x | 9.77x | 8.56x | 7.38x |
| EV / FCF | 25.4x | 25.5x | 63x | 132x | -82.5x | 12.7x | 19.6x | 16.1x |
| FCF Yield | 3.94% | 3.92% | 1.59% | 0.76% | -1.21% | 7.87% | 5.1% | 6.22% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 1.98 | 2.16 | 0.84 | -0.09 | -6.74 | 0.64 | 1.245 | 1.625 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 1,542 | 1,558 | 1,542 | 1,611 | 1,635 | 1,674 | 1,728 | 1,786 |
| EBITDA 1 | 400.7 | 411.3 | 369.7 | 322.2 | 317.5 | 344.3 | 363 | 385.9 |
| EBIT 1 | 314.1 | 366.6 | 329.1 | 281.1 | 274.8 | 297.6 | 315.9 | 336.3 |
| Net income 1 | 169.1 | 180.6 | 67.74 | -6.944 | -516.5 | 42.03 | 78.69 | 100.4 |
| Net Debt 1 | 1,033 | 986.7 | 1,200 | 1,535 | 1,596 | 1,489 | 1,285 | 1,064 |
| Reference price 2 | 66.99 | 56.07 | 43.55 | 22.68 | 12.42 | 18.24 | 18.24 | 18.24 |
| Nbr of stocks (in thousands) | 84,700 | 83,518 | 78,176 | 77,164 | 77,892 | 77,773 | - | - |
| Announcement Date | 2/23/22 | 2/22/23 | 2/28/24 | 2/25/25 | 2/26/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 27.16x | 1.7x | 8.25x | -.--% | 1.35B | |
| 31.83x | 4.29x | 16.61x | 2.32% | 192B | |
| 20.57x | 3.56x | 12.52x | 3.28% | 116B | |
| 17.2x | 0.2x | 12.44x | 0.76% | 59.95B | |
| 31.77x | 7.93x | 20.18x | 1.25% | 54.64B | |
| 37.93x | 3.42x | 11.71x | 2.14% | 50B | |
| 36.4x | 6.41x | 20.11x | -.--% | 34.26B | |
| 46.2x | 1.31x | 12.01x | 0.16% | 31.15B | |
| 41.08x | 7.2x | 25.83x | 0.26% | 24.79B | |
| 20.67x | 3.12x | 11.69x | 1.41% | 24.07B | |
| Average | 31.08x | 3.91x | 15.14x | 1.16% | 58.83B | |
| Weighted average by Cap. | 29.58x | 4.03x | 15.42x | 1.86% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- IART Stock
- Valuation Integra LifeSciences Holdings Corporation
Select your edition
All financial news and data tailored to specific country editions
